On Tuesday, Nektar Therapeutics (NASDAQ: NKTR) opened higher 0.99% from the last session, before settling in for the closing price of $1.01. Price fluctuations for NKTR have ranged from $0.46 to $1.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.42% over the last five years. Company’s average yearly earnings per share was noted 51.45% at the time writing. With a float of $178.21 million, this company’s outstanding shares have now reached $184.46 million.
The firm has a total of 137 workers. Let’s measure their productivity. In terms of profitability, gross margin is 67.8%, operating margin of -145.96%, and the pretax margin is -180.71%.
Nektar Therapeutics (NKTR) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Nektar Therapeutics is 3.39%, while institutional ownership is 74.38%. The most recent insider transaction that took place on Nov 19 ’24, was worth 7,863. In this transaction Chief R&D Officer of this company sold 7,785 shares at a rate of $1.01, taking the stock ownership to the 243,019 shares. Before that another transaction happened on Nov 19 ’24, when Company’s Chief Legal Officer sold 6,407 for $1.01, making the entire transaction worth $6,471. This insider now owns 218,856 shares in total.
Nektar Therapeutics (NKTR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.45% per share during the next fiscal year.
Nektar Therapeutics (NASDAQ: NKTR) Trading Performance Indicators
Check out the current performance indicators for Nektar Therapeutics (NKTR). In the past quarter, the stock posted a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.74 in one year’s time.
Technical Analysis of Nektar Therapeutics (NKTR)
Analysing the last 5-days average volume posted by the [Nektar Therapeutics, NKTR], we can find that recorded value of 3.48 million was better than the volume posted last year of 1.8 million. As of the previous 9 days, the stock’s Stochastic %D was 19.18%. Additionally, its Average True Range was 0.08.
During the past 100 days, Nektar Therapeutics’s (NKTR) raw stochastic average was set at 9.30%, which indicates a significant decrease from 20.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.77% in the past 14 days, which was lower than the 67.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2364, while its 200-day Moving Average is $1.2575. Now, the first resistance to watch is $1.0566. This is followed by the second major resistance level at $1.0932. The third major resistance level sits at $1.1265. If the price goes on to break the first support level at $0.9867, it is likely to go to the next support level at $0.9534. Should the price break the second support level, the third support level stands at $0.9168.
Nektar Therapeutics (NASDAQ: NKTR) Key Stats
There are currently 184,458K shares outstanding in the company with a market cap of 188.15 million. Presently, the company’s annual sales total 90,120 K according to its annual income of -276,060 K. Last quarter, the company’s sales amounted to 24,120 K and its income totaled -37,060 K.
